Study found DNA-based screen was more than 90 percent accurate in predicting recurrence
This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Zytiga shows benefits for treating late-stage disease, agency says
Thu Dec 13, 2012 10:34 PM
We care about your feedback. Let us know how we can improve your CancerCompass experience.